Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Esophageal Cancer AJCC v7”

124 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 124 results

Testing effectiveness (Phase 2)Study completedNCT00072033
What this trial is testing

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 66
Testing effectiveness (Phase 2)Study completedNCT00711412
What this trial is testing

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Northwestern University 44
Testing effectiveness (Phase 2)Study completedNCT00002984
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
UNC Lineberger Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00003237
What this trial is testing

Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Eastern Cooperative Oncology Group 55
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Very early researchWithdrawnNCT02857218
What this trial is testing

Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer

Who this might be right for
Stage IIB Esophageal Cancer AJCC v7Stage III Esophageal Cancer AJCC v7Stage IIIA Esophageal Cancer AJCC v7+2 more
OHSU Knight Cancer Institute
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00052910
What this trial is testing

Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 546
Early research (Phase 1)Study completedNCT00281788
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Duke University 13
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Testing effectiveness (Phase 2)Study completedNCT00003748
What this trial is testing

Irinotecan in Treating Patients With Esophageal or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Jonsson Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00045526
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionRecurrent Esophageal Cancer+3 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT00004233
What this trial is testing

S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
SWOG Cancer Research Network 65
Large-scale testing (Phase 3)Study completedNCT00002897
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
European Institute of Oncology 240
Testing effectiveness (Phase 2)Study completedNCT00033657
What this trial is testing

Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Eastern Cooperative Oncology Group 97
Testing effectiveness (Phase 2)Study completedNCT00021320
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Fox Chase Cancer Center 21
Not applicableStudy completedNCT00003321
What this trial is testing

Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 370
Early research (Phase 1)Study completedNCT00004257
What this trial is testing

Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer

Who this might be right for
Esophageal Cancer
Albany Medical College
Early research (Phase 1)WithdrawnNCT00025532
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer

Who this might be right for
Colorectal CancerEsophageal CancerGastric Cancer+1 more
University of California, San Francisco
Testing effectiveness (Phase 2)Study completedNCT00524121
What this trial is testing

Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer

Who this might be right for
Esophageal Cancer
Roswell Park Cancer Institute 22
Load More Results